David Shaw’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

David Shaw’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52M	Sell	328,794 -1,038,998	-76%	-$140M	0.02%	739
2026 Q1	$175M	Buy	1,367,792 +630,015	+85%	+$78.6M	0.11%	220
2025 Q4	$90M	Buy	+737,777	New	+$84.6M	0.05%	440
2025 Q3	–	Sell	-62,064	Closed	-$5.15M	–	4975
2025 Q2	$5.15M	Sell	62,064 -181,427	-75%	-$14.5M	﹤0.01%	2014
2025 Q1	$19.7M	Sell	243,491 -129,936	-35%	-$11.6M	0.02%	953
2024 Q4	$33.6M	Sell	373,427 -629,378	-63%	-$61M	0.02%	747
2024 Q3	$99.1M	Buy	+1,002,805	New	+$98.5M	0.09%	272
2024 Q2	–	Sell	-303,111	Closed	-$28.8M	–	4883
2024 Q1	$28.8M	Buy	+303,111	New	+$28.1M	0.02%	714
2023 Q2	–	Sell	-1,103,000	Closed	-$84.1M	–	4609
2023 Q1	$84.1M	Sell	1,103,000 -183,200	-14%	-$15.2M	0.09%	262
2022 Q4	$107M	Buy	1,286,200 +771,200	+150%	+$62.4M	0.12%	187
2022 Q3	$40.9M	Buy	+515,000	New	+$43.4M	0.05%	479
2021 Q2	–	Sell	-14,700	Closed	-$1.99M	–	5054
2021 Q1	$1.99M	Buy	+14,700	New	+$2.2M	﹤0.01%	2590
2020 Q2	–	Sell	-18,690	Closed	-$1.45M	–	4285
2020 Q1	$1.45M	Sell	18,690 -25,000	-57%	-$2.21M	﹤0.01%	2437
2019 Q4	$4.16M	Hold	43,690	–	–	﹤0.01%	1869
2019 Q3	$3.33M	Buy	+43,690	New	+$3.63M	﹤0.01%	1964
2017 Q1	–	Sell	-10,000	Closed	-$592K	–	3642
2016 Q4	$592K	Buy	+10,000	New	+$617K	﹤0.01%	2753
2016 Q3	–	Sell	-47,700	Closed	-$2.58M	–	3576
2016 Q2	$2.58M	Buy	+47,700	New	+$2.61M	﹤0.01%	1742

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

David Shaw's XBI Position: Q2 2026 in Review

David Shaw reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 76% in Q2 2026, selling an estimated $140M and leaving 328,794 shares worth $52M. The position accounts for 0.02% of the portfolio, ranked #739.

David Shaw first reported a position in XBI in Q2 2016 and has held it in 17 quarters since. The position peaked at $175M in Q1 2026. 931 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

David Shaw held 328,794 shares of State Street SPDR S&P Biotech ETF worth $52M as of Q2 2026.
David Shaw sold 1,038,998 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $140M.
State Street SPDR S&P Biotech ETF made up 0.02% of David Shaw's portfolio in Q2 2026, its #739 holding.
David Shaw first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and has held it in 17 quarters since.
David Shaw's State Street SPDR S&P Biotech ETF position peaked at $175M in Q1 2026.
931 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.